Immune Responses in Human Colon Cancer. II. Cytotoxic Antibody Detected in Patients' Sera

Immune Responses in Human Colon Cancer. II. Cytotoxic Antibody Detected in Patients' Sera

Complement-dependent cytotoxicity (CDC), antibody-dependent cell-mediated cytotoxicity (ADCC), and spontaneous cell-mediated cytotoxicity (SCM C) were evaluated in patients with colon cancer with the use of a 51Cr release microcytotoxicity assay. We studied the sera and peripheral blood lymphocytes...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:JNCI : Journal of the National Cancer Institute 1978-04, Vol.60 (4), p.779-784
Hauptverfasser: Hahn, William V., Kagnoff, Martin F., Hatlen, Loren H.
Format: Artikel
Sprache:eng
Schlagworte:
Antibodies, Neoplasm
Antibody-Dependent Cell Cytotoxicity
Antigens, Neoplasm
Cell Line
Colonic Neoplasms - immunology
Complement System Proteins
Cytotoxicity, Immunologic
Epitopes
Humans
Immunoglobulin G
Lymphocytes - immunology
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 784
container_issue 4
container_start_page 779
container_title JNCI : Journal of the National Cancer Institute
container_volume 60
creator Hahn, William V.
Kagnoff, Martin F.
Hatlen, Loren H.
description Complement-dependent cytotoxicity (CDC), antibody-dependent cell-mediated cytotoxicity (ADCC), and spontaneous cell-mediated cytotoxicity (SCM C) were evaluated in patients with colon cancer with the use of a 51Cr release microcytotoxicity assay. We studied the sera and peripheral blood lymphocytes (PBL) from patients with colon cancer as well as from normal controls using three separate human colon cancer cell lines as targets. Antibody active in either the CDC or ADCC assay was detected in 11 of 14 (79%) patients with colon cancer, but none was found in 18 normal individuals. The ability of PBL from patients with colon cancer and from normal controls to mediate ADCC and SCMC did not differ significantly.
doi_str_mv 10.1093/jnci/60.4.779
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_83881633</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>83881633</sourcerecordid><originalsourceid>FETCH-LOGICAL-i157t-b0b68942c3d4d0baa6340475196c2b9d3c6a004a747acd02bc7536ddc4e285da3</originalsourceid><addsrcrecordid>eNo9kD1PwzAURS1EBaUwMrF4gimpEzt2MpYUSKRKoPLNYjm2kVwSp8SO1P57Aq24w7vDOe8ND4DzCIURyvB0ZaWZUhSSkLHsAIwjQlEQRyg5BGOEYhakKSPH4MS5FRqSxeQIjFiSsWwM3sum6a2GS-3WrXXaQWNh0TfCwryt22EKK3UXwrIMYb71rW83RsKZ9aZq1RbOtdfSa_W79iC80da7K_ioO3EKRp-idvps3xPwfHvzlBfB4v6uzGeLwEQJ80GFKppmJJZYEYUqISgmiLAkyqiMq0xhSQVCRDDChFQoriRLMFVKEh2niRJ4Ai53d9dd-91r53ljnNR1Laxue8dTnKYRxXgQL_ZiXzVa8XVnGtFt-d8nBhrsqHFeb_6h6L44ZZglvHj74NevL8UyKWI-xz86c242</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>83881633</pqid></control><display><type>article</type><title>Immune Responses in Human Colon Cancer. II. Cytotoxic Antibody Detected in Patients' Sera</title><source>MEDLINE</source><source>Oxford University Press Journals Digital Archive Legacy</source><creator>Hahn, William V. ; Kagnoff, Martin F. ; Hatlen, Loren H.</creator><creatorcontrib>Hahn, William V. ; Kagnoff, Martin F. ; Hatlen, Loren H.</creatorcontrib><description>Complement-dependent cytotoxicity (CDC), antibody-dependent cell-mediated cytotoxicity (ADCC), and spontaneous cell-mediated cytotoxicity (SCM C) were evaluated in patients with colon cancer with the use of a 51Cr release microcytotoxicity assay. We studied the sera and peripheral blood lymphocytes (PBL) from patients with colon cancer as well as from normal controls using three separate human colon cancer cell lines as targets. Antibody active in either the CDC or ADCC assay was detected in 11 of 14 (79%) patients with colon cancer, but none was found in 18 normal individuals. The ability of PBL from patients with colon cancer and from normal controls to mediate ADCC and SCMC did not differ significantly.</description><identifier>ISSN: 0027-8874</identifier><identifier>EISSN: 1460-2105</identifier><identifier>DOI: 10.1093/jnci/60.4.779</identifier><identifier>PMID: 75979</identifier><language>eng</language><publisher>United States: Oxford University Press</publisher><subject>Antibodies, Neoplasm ; Antibody-Dependent Cell Cytotoxicity ; Antigens, Neoplasm ; Cell Line ; Colonic Neoplasms - immunology ; Complement System Proteins ; Cytotoxicity, Immunologic ; Epitopes ; Humans ; Immunoglobulin G ; Lymphocytes - immunology</subject><ispartof>JNCI : Journal of the National Cancer Institute, 1978-04, Vol.60 (4), p.779-784</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/75979$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hahn, William V.</creatorcontrib><creatorcontrib>Kagnoff, Martin F.</creatorcontrib><creatorcontrib>Hatlen, Loren H.</creatorcontrib><title>Immune Responses in Human Colon Cancer. II. Cytotoxic Antibody Detected in Patients' Sera</title><title>JNCI : Journal of the National Cancer Institute</title><addtitle>Journal of the National Cancer Institute</addtitle><description>Complement-dependent cytotoxicity (CDC), antibody-dependent cell-mediated cytotoxicity (ADCC), and spontaneous cell-mediated cytotoxicity (SCM C) were evaluated in patients with colon cancer with the use of a 51Cr release microcytotoxicity assay. We studied the sera and peripheral blood lymphocytes (PBL) from patients with colon cancer as well as from normal controls using three separate human colon cancer cell lines as targets. Antibody active in either the CDC or ADCC assay was detected in 11 of 14 (79%) patients with colon cancer, but none was found in 18 normal individuals. The ability of PBL from patients with colon cancer and from normal controls to mediate ADCC and SCMC did not differ significantly.</description><subject>Antibodies, Neoplasm</subject><subject>Antibody-Dependent Cell Cytotoxicity</subject><subject>Antigens, Neoplasm</subject><subject>Cell Line</subject><subject>Colonic Neoplasms - immunology</subject><subject>Complement System Proteins</subject><subject>Cytotoxicity, Immunologic</subject><subject>Epitopes</subject><subject>Humans</subject><subject>Immunoglobulin G</subject><subject>Lymphocytes - immunology</subject><issn>0027-8874</issn><issn>1460-2105</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1978</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kD1PwzAURS1EBaUwMrF4gimpEzt2MpYUSKRKoPLNYjm2kVwSp8SO1P57Aq24w7vDOe8ND4DzCIURyvB0ZaWZUhSSkLHsAIwjQlEQRyg5BGOEYhakKSPH4MS5FRqSxeQIjFiSsWwM3sum6a2GS-3WrXXaQWNh0TfCwryt22EKK3UXwrIMYb71rW83RsKZ9aZq1RbOtdfSa_W79iC80da7K_ioO3EKRp-idvps3xPwfHvzlBfB4v6uzGeLwEQJ80GFKppmJJZYEYUqISgmiLAkyqiMq0xhSQVCRDDChFQoriRLMFVKEh2niRJ4Ai53d9dd-91r53ljnNR1Laxue8dTnKYRxXgQL_ZiXzVa8XVnGtFt-d8nBhrsqHFeb_6h6L44ZZglvHj74NevL8UyKWI-xz86c242</recordid><startdate>197804</startdate><enddate>197804</enddate><creator>Hahn, William V.</creator><creator>Kagnoff, Martin F.</creator><creator>Hatlen, Loren H.</creator><general>Oxford University Press</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>197804</creationdate><title>Immune Responses in Human Colon Cancer. II. Cytotoxic Antibody Detected in Patients' Sera</title><author>Hahn, William V. ; Kagnoff, Martin F. ; Hatlen, Loren H.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-i157t-b0b68942c3d4d0baa6340475196c2b9d3c6a004a747acd02bc7536ddc4e285da3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1978</creationdate><topic>Antibodies, Neoplasm</topic><topic>Antibody-Dependent Cell Cytotoxicity</topic><topic>Antigens, Neoplasm</topic><topic>Cell Line</topic><topic>Colonic Neoplasms - immunology</topic><topic>Complement System Proteins</topic><topic>Cytotoxicity, Immunologic</topic><topic>Epitopes</topic><topic>Humans</topic><topic>Immunoglobulin G</topic><topic>Lymphocytes - immunology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hahn, William V.</creatorcontrib><creatorcontrib>Kagnoff, Martin F.</creatorcontrib><creatorcontrib>Hatlen, Loren H.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>JNCI : Journal of the National Cancer Institute</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hahn, William V.</au><au>Kagnoff, Martin F.</au><au>Hatlen, Loren H.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Immune Responses in Human Colon Cancer. II. Cytotoxic Antibody Detected in Patients' Sera</atitle><jtitle>JNCI : Journal of the National Cancer Institute</jtitle><addtitle>Journal of the National Cancer Institute</addtitle><date>1978-04</date><risdate>1978</risdate><volume>60</volume><issue>4</issue><spage>779</spage><epage>784</epage><pages>779-784</pages><issn>0027-8874</issn><eissn>1460-2105</eissn><abstract>Complement-dependent cytotoxicity (CDC), antibody-dependent cell-mediated cytotoxicity (ADCC), and spontaneous cell-mediated cytotoxicity (SCM C) were evaluated in patients with colon cancer with the use of a 51Cr release microcytotoxicity assay. We studied the sera and peripheral blood lymphocytes (PBL) from patients with colon cancer as well as from normal controls using three separate human colon cancer cell lines as targets. Antibody active in either the CDC or ADCC assay was detected in 11 of 14 (79%) patients with colon cancer, but none was found in 18 normal individuals. The ability of PBL from patients with colon cancer and from normal controls to mediate ADCC and SCMC did not differ significantly.</abstract><cop>United States</cop><pub>Oxford University Press</pub><pmid>75979</pmid><doi>10.1093/jnci/60.4.779</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0027-8874
ispartof JNCI : Journal of the National Cancer Institute, 1978-04, Vol.60 (4), p.779-784
issn 0027-8874
1460-2105
language eng
recordid cdi_proquest_miscellaneous_83881633
source MEDLINE; Oxford University Press Journals Digital Archive Legacy
subjects Antibodies, Neoplasm
Antibody-Dependent Cell Cytotoxicity
Antigens, Neoplasm
Cell Line
Colonic Neoplasms - immunology
Complement System Proteins
Cytotoxicity, Immunologic
Epitopes
Humans
Immunoglobulin G
Lymphocytes - immunology
title Immune Responses in Human Colon Cancer. II. Cytotoxic Antibody Detected in Patients' Sera
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T03%3A32%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Immune%20Responses%20in%20Human%20Colon%20Cancer.%20II.%20Cytotoxic%20Antibody%20Detected%20in%20Patients'%20Sera&rft.jtitle=JNCI%20:%20Journal%20of%20the%20National%20Cancer%20Institute&rft.au=Hahn,%20William%20V.&rft.date=1978-04&rft.volume=60&rft.issue=4&rft.spage=779&rft.epage=784&rft.pages=779-784&rft.issn=0027-8874&rft.eissn=1460-2105&rft_id=info:doi/10.1093/jnci/60.4.779&rft_dat=%3Cproquest_pubme%3E83881633%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=83881633&rft_id=info:pmid/75979&rfr_iscdi=true